Polypharmacy and relapse of schizophrenia: are they related?

Introduction Polypharmacy can be the cause of deliberate discontinuation of medication and consequent relapse of schizophrenia. Objectives To establish the one-year rate of relapse in the patients with schizophrenia with regard to monotherapy or polypharmacy. Methods The sample of all hospitalize...

Full description

Bibliographic Details
Main Authors: R. Softic, S. Osmanovic, N. Becarevic
Format: Article
Language:English
Published: Cambridge University Press 2022-06-01
Series:European Psychiatry
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S0924933822019757/type/journal_article
_version_ 1797616524638289920
author R. Softic
S. Osmanovic
N. Becarevic
author_facet R. Softic
S. Osmanovic
N. Becarevic
author_sort R. Softic
collection DOAJ
description Introduction Polypharmacy can be the cause of deliberate discontinuation of medication and consequent relapse of schizophrenia. Objectives To establish the one-year rate of relapse in the patients with schizophrenia with regard to monotherapy or polypharmacy. Methods The sample of all hospitalized patients with schizophrenia in a five-year period was analyzed. Descriptive statistics were used. Results Total of 87 participants (57 women), the median age was 43 years. Antipsychotic monotherapy was used in 31 (35.6%) of the participants. In one year period, 32 (36.8%) of all participants had a relapse. Prior to relapse, significantly more participants were treated with polypharmacy (p<0,05). Conclusions Antipsychotic polypharmacy is related to a higher rate of relapse in patients with schizophrenia. Disclosure No significant relationships.
first_indexed 2024-03-11T07:42:27Z
format Article
id doaj.art-b5e5118126f64cc0b6f86ed6b7176c66
institution Directory Open Access Journal
issn 0924-9338
1778-3585
language English
last_indexed 2024-03-11T07:42:27Z
publishDate 2022-06-01
publisher Cambridge University Press
record_format Article
series European Psychiatry
spelling doaj.art-b5e5118126f64cc0b6f86ed6b7176c662023-11-17T05:08:23ZengCambridge University PressEuropean Psychiatry0924-93381778-35852022-06-0165S765S76510.1192/j.eurpsy.2022.1975Polypharmacy and relapse of schizophrenia: are they related?R. Softic0S. Osmanovic1N. Becarevic2University Clinical Center Tuzla, Of Psychiatry, Tuzla, Bosnia and HerzegovinaHealth Center Brčko, Of Psychiatry, Brčko, Bosnia and HerzegovinaUniversity Clinical Center Tuzla, Of Psychiatry, Tuzla, Bosnia and Herzegovina Introduction Polypharmacy can be the cause of deliberate discontinuation of medication and consequent relapse of schizophrenia. Objectives To establish the one-year rate of relapse in the patients with schizophrenia with regard to monotherapy or polypharmacy. Methods The sample of all hospitalized patients with schizophrenia in a five-year period was analyzed. Descriptive statistics were used. Results Total of 87 participants (57 women), the median age was 43 years. Antipsychotic monotherapy was used in 31 (35.6%) of the participants. In one year period, 32 (36.8%) of all participants had a relapse. Prior to relapse, significantly more participants were treated with polypharmacy (p<0,05). Conclusions Antipsychotic polypharmacy is related to a higher rate of relapse in patients with schizophrenia. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S0924933822019757/type/journal_articleschizophréniaRelapsePolypharmacy
spellingShingle R. Softic
S. Osmanovic
N. Becarevic
Polypharmacy and relapse of schizophrenia: are they related?
European Psychiatry
schizophrénia
Relapse
Polypharmacy
title Polypharmacy and relapse of schizophrenia: are they related?
title_full Polypharmacy and relapse of schizophrenia: are they related?
title_fullStr Polypharmacy and relapse of schizophrenia: are they related?
title_full_unstemmed Polypharmacy and relapse of schizophrenia: are they related?
title_short Polypharmacy and relapse of schizophrenia: are they related?
title_sort polypharmacy and relapse of schizophrenia are they related
topic schizophrénia
Relapse
Polypharmacy
url https://www.cambridge.org/core/product/identifier/S0924933822019757/type/journal_article
work_keys_str_mv AT rsoftic polypharmacyandrelapseofschizophreniaaretheyrelated
AT sosmanovic polypharmacyandrelapseofschizophreniaaretheyrelated
AT nbecarevic polypharmacyandrelapseofschizophreniaaretheyrelated